Hemin-MC-EXO targets HMGB1 high mobility group box-1 (HMGB1) to deliver miR-183-5p to cardiomyocytes to inhibit their senescence, emphasizing its value in the repair of MI rat models (101). The gene discussed is HMGB1; the disease is myocardial infarction.